CAR-T Safe in Myeloma Patients With Autoimmune Diseases, Small Study Finds

By News Health
20 hours Ago

(MedPage Today) — A retrospective study presented at the recent American Society of Clinical Oncology (ASCO) meeting suggested that patients with autoimmune diseases may safely receive idecabtagene vicleucel (ide-cel; Abecma) for relapsed or refractory…

Source link : https://www.medpagetoday.com/meetingcoverage/ascovideopearlsmm/116052

Author :

Publish date : 2025-06-13 12:40:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

I'm an NHS leader - but my mum still suffered at hands of the health service

Mood swings fuelled the chef's genius. But the highs got higher and the lows got darker

Abortion access in second trimester 'worst in the UK' in Wales

How a US agriculture agency became key in the fight against bird flu

Allergy Meds a Contributing Factor in Medical Flight Crash, Investigation Finds

Earth’s mantle may have hidden plumes venting heat from its core